KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Change in Acquisitions & Divestments (2020 - 2025)

Neogenomics (NEO) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $9.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 23.58% year-over-year to $9.0 million, compared with a TTM value of $20.1 million through Dec 2025, down 62.79%, and an annual FY2025 reading of $20.1 million, down 62.79% over the prior year.
  • Change in Acquisitions & Divestments was $9.0 million for Q3 2025 at Neogenomics, up from $3.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $40.4 million in Q1 2023 and bottomed at $3.0 million in Q2 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $19.3 million, with a median of $20.1 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments surged 673.94% in 2021, then crashed 85.29% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $18.2 million in 2021, then skyrocketed by 48.64% to $27.1 million in 2022, then decreased by 10.52% to $24.3 million in 2023, then plummeted by 74.72% to $6.1 million in 2024, then soared by 46.77% to $9.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for NEO at $9.0 million in Q3 2025, $3.0 million in Q2 2025, and $8.1 million in Q1 2025.